V+PSF-M for Tobacco Cessation in HIV Care in India

Recruiting now · Phase 3

Conditions studied: Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco

In brief

The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)

Key facts

Study ID
NCT05786547
Run by
University of Colorado, Denver
People needed
400
Starts
2024-01-02
Expected to finish
2026-07-22
Last updated by the study team
2025-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.